Literature DB >> 23746054

Dynamics of immune effector mechanisms during infection with Mycobacterium avium in C57BL/6 mice.

Markus Haug1, Jane A Awuh, Magnus Steigedal, June Frengen Kojen, Anne Marstad, Ivar S Nordrum, Øyvind Halaas, Trude H Flo.   

Abstract

Opportunistic infections with non-tuberculous mycobacteria such as Mycobacterium avium are receiving renewed attention because of increased incidence and difficulties in treatment. As for other mycobacterial infections, a still poorly understood collaboration of different immune effector mechanisms is required to confer protective immunity. Here we have characterized the interplay of innate and adaptive immune effector mechanisms contributing to containment in a mouse infection model using virulent M. avium strain 104 in C57BL/6 mice. M. avium caused chronic infection in mice, as shown by sustained organ bacterial load. In the liver, bacteria were contained in granuloma-like structures that could be defined morphologically by expression of the antibacterial innate effector protein Lipocalin 2 in the adjoining hepatocytes and infiltrating neutrophils, possibly contributing to containment. Circulatory anti-mycobacterial antibodies steadily increased throughout infection and were primarily of the IgM isotype. Highest levels of interferon-γ were found in infected liver, spleen and serum of mice approximately 2 weeks post infection and coincided with a halt in organ bacterial growth. In contrast, expression of tumour necrosis factor was surprisingly low in spleen compared with liver. We did not detect interleukin-17 in infected organs or M. avium-specific T helper 17 cells, suggesting a minor role for T helper 17 cells in this model. A transient and relative decrease in regulatory T cell numbers was seen in spleens. This detailed characterization of M. avium infection in C57BL/6 mice may provide a basis for future studies aimed at gaining better insight into mechanisms leading to containment of infections with non-tuberculous mycobacteria.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  CD4+ T cell subsets; Mycobacterium avium; adaptive immune response; inflammation; mouse infection model

Mesh:

Substances:

Year:  2013        PMID: 23746054      PMCID: PMC3784169          DOI: 10.1111/imm.12131

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  77 in total

1.  Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis.

Authors:  Jia Yao Phuah; Joshua T Mattila; Philana L Lin; JoAnne L Flynn
Journal:  Am J Pathol       Date:  2012-06-19       Impact factor: 4.307

2.  Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection.

Authors:  Andrea Cruz; Shabaana A Khader; Egidio Torrado; Alexandra Fraga; John E Pearl; Jorge Pedrosa; Andrea M Cooper; António G Castro
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

3.  IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge.

Authors:  Shabaana A Khader; Guy K Bell; John E Pearl; Jeffrey J Fountain; Javier Rangel-Moreno; Garth E Cilley; Fang Shen; Sheri M Eaton; Sarah L Gaffen; Susan L Swain; Richard M Locksley; Laura Haynes; Troy D Randall; Andrea M Cooper
Journal:  Nat Immunol       Date:  2007-03-11       Impact factor: 25.606

Review 4.  Pathogenesis of Mycobacterium avium infection: typical responses to an atypical mycobacterium?

Authors:  Rui Appelberg
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Mycobacteria-induced anaemia revisited: a molecular approach reveals the involvement of NRAMP1 and lipocalin-2, but not of hepcidin.

Authors:  Pedro N Rodrigues; Sandro S Gomes; João V Neves; Sandra Gomes-Pereira; Margarida Correia-Neves; Cláudio Nunes-Alves; Jens Stolte; Mayka Sanchez; Rui Appelberg; Martina U Muckenthaler; M Salomé Gomes
Journal:  Immunobiology       Date:  2011-04-20       Impact factor: 3.144

6.  IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection.

Authors:  Euan Lockhart; Angela M Green; JoAnne L Flynn
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

Review 7.  Initiation and regulation of T-cell responses in tuberculosis.

Authors:  K B Urdahl; S Shafiani; J D Ernst
Journal:  Mucosal Immunol       Date:  2011-03-30       Impact factor: 7.313

8.  Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice.

Authors:  Evelyn Guirado; Isabel Amat; Olga Gil; Jorge Díaz; Virginia Arcos; Neus Caceres; Vicenç Ausina; Pere-Joan Cardona
Journal:  Microbes Infect       Date:  2006-01-27       Impact factor: 2.700

Review 9.  Therapy of refractory nontuberculous mycobacterial lung disease.

Authors:  David E Griffith; Timothy R Aksamit
Journal:  Curr Opin Infect Dis       Date:  2012-04       Impact factor: 4.915

10.  IRF8 mutations and human dendritic-cell immunodeficiency.

Authors:  Sophie Hambleton; Sandra Salem; Jacinta Bustamante; Venetia Bigley; Stéphanie Boisson-Dupuis; Joana Azevedo; Anny Fortin; Muzlifah Haniffa; Lourdes Ceron-Gutierrez; Chris M Bacon; Geetha Menon; Céline Trouillet; David McDonald; Peter Carey; Florent Ginhoux; Laia Alsina; Timothy J Zumwalt; Xiao-Fei Kong; Dinakantha Kumararatne; Karina Butler; Marjorie Hubeau; Jacqueline Feinberg; Saleh Al-Muhsen; Andrew Cant; Laurent Abel; Damien Chaussabel; Rainer Doffinger; Eduardo Talesnik; Anete Grumach; Alberto Duarte; Katia Abarca; Dewton Moraes-Vasconcelos; David Burk; Albert Berghuis; Frédéric Geissmann; Matthew Collin; Jean-Laurent Casanova; Philippe Gros
Journal:  N Engl J Med       Date:  2011-04-27       Impact factor: 91.245

View more
  12 in total

1.  Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.

Authors:  Magnus Steigedal; Anne Marstad; Markus Haug; Jan K Damås; Roland K Strong; Pacita L Roberts; Stephanie D Himpsl; Ann Stapleton; Thomas M Hooton; Harry L T Mobley; Thomas R Hawn; Trude H Flo
Journal:  J Immunol       Date:  2014-11-14       Impact factor: 5.422

2.  Interferon-β controls non-tuberculous mycobacterial infection in mice.

Authors:  Mohd-Nor Norazmi
Journal:  Virulence       Date:  2017-06-12       Impact factor: 5.882

3.  Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models.

Authors:  Andrés Obregón-Henao; Kimberly A Arnett; Marcela Henao-Tamayo; Lisa Massoudi; Elizabeth Creissen; Koen Andries; Anne J Lenaerts; Diane J Ordway
Journal:  Antimicrob Agents Chemother       Date:  2015-08-24       Impact factor: 5.191

4.  Mycobacterium vaccae induces a strong Th1 response that subsequently declines in C57BL/6 mice.

Authors:  Lijiao Zhang; Yanlong Jiang; Ziyin Cui; Wentao Yang; Limin Yue; Yingcong Ma; Shaohua Shi; Chunfang Wang; Chunfeng Wang; Aidong Qian
Journal:  J Vet Sci       Date:  2016-12-30       Impact factor: 1.672

5.  Photochemical Internalization of Peptide Antigens Provides a Novel Strategy to Realize Therapeutic Cancer Vaccination.

Authors:  Markus Haug; Gaute Brede; Monika Håkerud; Anne Grete Nedberg; Odrun A Gederaas; Trude H Flo; Victoria T Edwards; Pål K Selbo; Anders Høgset; Øyvind Halaas
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

6.  Mycobacterium smegmatis Vaccine Vector Elicits CD4+ Th17 and CD8+ Tc17 T Cells With Therapeutic Potential to Infections With Mycobacterium avium.

Authors:  Nisha Kannan; Markus Haug; Magnus Steigedal; Trude Helen Flo
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

7.  The protective effects of oral low-dose quercetin on diabetic nephropathy in hypercholesterolemic mice.

Authors:  Isabele B S Gomes; Marcella L Porto; Maria C L F S Santos; Bianca P Campagnaro; Agata L Gava; Silvana S Meyrelles; Thiago M C Pereira; Elisardo C Vasquez
Journal:  Front Physiol       Date:  2015-09-02       Impact factor: 4.566

8.  Presence of Infected Gr-1intCD11bhiCD11cint Monocytic Myeloid Derived Suppressor Cells Subverts T Cell Response and Is Associated With Impaired Dendritic Cell Function in Mycobacterium avium-Infected Mice.

Authors:  Ketema Abdissa; Andreas Nerlich; Andreas Beineke; Nanthapon Ruangkiattikul; Vinay Pawar; Ulrike Heise; Nina Janze; Christine Falk; Dunja Bruder; Ulrike Schleicher; Christian Bogdan; Siegfried Weiss; Ralph Goethe
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

9.  Genetic Variation/Evolution and Differential Host Responses Resulting from In-Patient Adaptation of Mycobacterium avium.

Authors:  T H Flo; M Steigedal; N Kannan; Y-P Lai; M Haug; M K Lilleness; S S Bakke; A Marstad; H Hov; T Naustdal; J E Afset; T R Ioerger
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

10.  Nontuberculous mycobacterium M. avium infection predisposes aged mice to cardiac abnormalities and inflammation.

Authors:  Colwyn A Headley; Abigail Gerberick; Sumiran Mehta; Qian Wu; Lianbo Yu; Paolo Fadda; Mahmood Khan; Latha Prabha Ganesan; Joanne Turner; Murugesan V S Rajaram
Journal:  Aging Cell       Date:  2019-03-04       Impact factor: 11.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.